ENH move IL2 stuff to its own section
This commit is contained in:
parent
54fb855b19
commit
1c65546e41
|
@ -2168,7 +2168,7 @@ Venn diagram from the venn R package.
|
|||
|
||||
\section{results}
|
||||
|
||||
\subsection{DOE shows optimal conditions for expanded potent T cells}
|
||||
\subsection{T cells can be grown on DMSs with lower IL2 concentrations}
|
||||
|
||||
% TODO this plots proportions look dumb
|
||||
\begin{figure*}[ht!]
|
||||
|
@ -2194,6 +2194,10 @@ Venn diagram from the venn R package.
|
|||
\label{fig:il2_mod}
|
||||
\end{figure*}
|
||||
|
||||
% TODO this is not consistent with the next section since the responses are
|
||||
% different
|
||||
\subsection{DOE shows optimal conditions for expanded potent T cells}
|
||||
|
||||
% TODO not all of these were actually use, explain why by either adding columns
|
||||
% or marking with an asterisk
|
||||
\begin{table}[!h] \centering
|
||||
|
@ -2284,14 +2288,15 @@ process (Fig.1d-e).
|
|||
\end{table}
|
||||
|
||||
SR models achieved the highest predictive performance (R2>93\%) when using
|
||||
multi-omics predictors for all endpoint responses (\cref{tab:mod_results}). SR achieved R2>98\%
|
||||
while GBM tree-based ensembles showed leave-one-out cross-validated R2 (LOO-R2)
|
||||
>95\% for CD4+ and CD4+/CD8+ TN+TCM responses. Similarly, LASSO, PLSR, and SVM
|
||||
methods showed consistent high LOO-R2, 92.9\%, 99.7\%, and 90.5\%, respectively,
|
||||
to predict the CD4+/CD8+ TN+TCM. Yet, about 10\% reduction in LOO-R2,
|
||||
72.5\%-81.7\%, was observed for CD4+ TN+TCM with these three methods. Lastly, SR
|
||||
and PLSR achieved R2>90\% while other ML methods exhibited exceedingly variable
|
||||
LOO-R2 (0.3\%,RF-51.5\%,LASSO) for CD8+ TN+TCM cells.
|
||||
multi-omics predictors for all endpoint responses (\cref{tab:mod_results}). SR
|
||||
achieved R2>98\% while GBM tree-based ensembles showed leave-one-out
|
||||
cross-validated R2 (LOO-R2) >95\% for CD4+ and CD4+/CD8+ TN+TCM responses.
|
||||
Similarly, LASSO, PLSR, and SVM methods showed consistent high LOO-R2, 92.9\%,
|
||||
99.7\%, and 90.5\%, respectively, to predict the CD4+/CD8+ TN+TCM. Yet, about
|
||||
10\% reduction in LOO-R2, 72.5\%-81.7\%, was observed for CD4+ TN+TCM with these
|
||||
three methods. Lastly, SR and PLSR achieved R2>90\% while other ML methods
|
||||
exhibited exceedingly variable LOO-R2 (0.3\%,RF-51.5\%,LASSO) for CD8+ TN+TCM
|
||||
cells.
|
||||
|
||||
% FIGURE the CD4/CD8 model results using SR
|
||||
|
||||
|
|
Loading…
Reference in New Issue